Company intelligence / Profile preview

Anatara Lifesciences

Brisbane, Queensland, Australiaanataralifesciences.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Currently conducting Phase II clinical trials for GaRP-IBS treatment. Stage 1 of the trial completed in late 2023 with promising results, meeting all predefined endpoints. Stage 2 of the Phase II trial is now underway.

Therapeutic areas: GastroenterologyEndocrinology
Modalities: Complementary medicinedietary supplements
Industry: Biotech

Drug pipeline

1 asset

Anatara Lifesciences anti-obesity program

Preclinical

Partnerships

ObvioHealth (for clinical trials)

Beyond the preview

Go deeper on Anatara Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anatara Lifesciences.

Explore the full profile